【结 构 式】 |
【分子编号】55069 【品名】(2R)-1,3-oxathiolan-2-ylmethanol 【CA登记号】 |
【 分 子 式 】C4H8O2S 【 分 子 量 】120.17232 【元素组成】C 39.98% H 6.71% O 26.63% S 26.68% |
合成路线1
该中间体在本合成路线中的序号:(III)The title compound was prepared starting from the known menthyl 5(S)-acetoxy-1,3-oxathiolan-2(R)-carboxylate (I). Transposition of the 5-acetoxy group of (I) to the target 4-acetoxy derivative (VI) was achieved by the following sequence. The acetoxy group of (I) was first removed by reduction with triethylsilaneto give (II), followed by ester reduction with NaBH4, to give the hydroxymethyl oxathiolane (III). The primary alcohol of (III) was then protected by silylation with tert-butyldiphenylsilyl chloride. The resultant silylated oxathiolane (IV) was oxidized to a diastereomeric mixture of sulfoxides (V) using m-CPBA. Pummerer rearrangement of sulfoxides (V) in the presence of Ac2O and Bu4NOAc furnished the desired 4-acetoxy thiolane (VI). Glycosylation of (VI) with N-acetylcytosine (VII) in the presence of trimethylsilyl triflate provided a mixture of cis- and trans-coupled products, which were separated by preparative TLC. The required cis-isomer (VIII) was desilylated with tetrabutylammonium fluoride, followed by acetamide hydrolysis with K2CO3 in MeOH, to provide the title compound.
【1】 Mansour, T.S.; et al.; Structure-activity relationships among a new class of antiviral heterosubstituted 2',3'-dideoxynucleoside analogs. Nucleosides Nucleotides 1995, 14, 3-5, 627. |
【2】 Wang, W.; et al.; Synthesis of optically active 2',3'-dideoxy-3'-oxa-4'-thio-ribonucleoside analogs by transposition of a leaving group on chiral oxathiolanes via a reductive-oxidative process. Tetrahedron Lett 1994, 35, 27, 4739. |
【3】 Mansour, T.S.; et al.; Anti-human immunodeficiency virus and anti-hepatitis-B virus activities and toxicities of the enantiomers of 2'-deoxy-3'-oxa-4'-thiocytidine and their 5-fluoro analogues in vitro. J Med Chem 1995, 38, 1, 1. |
【4】 Mansour, T.S.; Jin, H. (Shire BioChem Inc.); Substd. 1,3-oxathiolanes with antiviral properties. EP 0756595; EP 1153924; JP 1997512526; WO 9529176 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 55067 | (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (2R,5R)-5-(acetyloxy)-1,3-oxathiolane-2-carboxylate | C16H26O5S | 详情 | 详情 | |
(II) | 55068 | (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (2R)-1,3-oxathiolane-2-carboxylate | C14H24O3S | 详情 | 详情 | |
(III) | 55069 | (2R)-1,3-oxathiolan-2-ylmethanol | C4H8O2S | 详情 | 详情 | |
(IV) | 55070 | tert-butyl[(2R)-1,3-oxathiolan-2-ylmethoxy]diphenylsilane; tert-butyl(diphenyl)silyl (2R)-1,3-oxathiolan-2-ylmethyl ether | C20H26O2SSi | 详情 | 详情 | |
(V) | 55071 | (2R)-2-({[tert-butyl(diphenyl)silyl]oxy}methyl)-1,3lambda~4~-oxathiolan-3-one | C20H26O3SSi | 详情 | 详情 | |
(VI) | 55072 | (2R)-2-({[tert-butyl(diphenyl)silyl]oxy}methyl)-1,3-oxathiolan-4-yl acetate | C22H28O4SSi | 详情 | 详情 | |
(VII) | 55073 | N(4)-Acetylcytosine | 14631-20-0 | C6H7N3O2 | 详情 | 详情 |
(VIII) | 55074 | N-{1-[(2R,4R)-2-({[tert-butyl(diphenyl)silyl]oxy}methyl)-1,3-oxathiolan-4-yl]-2-oxo-1,2-dihydro-4-pyrimidinyl}acetamide | C26H31N3O4SSi | 详情 | 详情 |